Page last updated: 2024-10-20

trimethylamine and Hemolysis

trimethylamine has been researched along with Hemolysis in 1 studies

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research Excerpts

ExcerptRelevanceReference
"Gefitinib (Gf) was selected as a model drug and entrapped in between exfoliated GO sheets (GOIGF) via π-π* stacking before functionalization with IONPs."1.56Development of amine-functionalized superparamagnetic iron oxide nanoparticles anchored graphene nanosheets as a possible theranostic agent in cancer metastasis. ( Deshmukh, PK; More, MP, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
More, MP1
Deshmukh, PK1

Other Studies

1 other study available for trimethylamine and Hemolysis

ArticleYear
Development of amine-functionalized superparamagnetic iron oxide nanoparticles anchored graphene nanosheets as a possible theranostic agent in cancer metastasis.
    Drug delivery and translational research, 2020, Volume: 10, Issue:4

    Topics: Amines; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Liberation; Erythrocytes; Ferri

2020